Motion Equity Partners takes majority stake in omega-3 microalgae biotech Polaris
Polaris Inc.
Polaris Inc. PII | 0.00 |
- Motion Equity Partners took a majority stake in Polaris in a private financing round alongside reinvesting existing shareholders.
- Polaris, founded in 1994 and based in Quimper, produces high-concentration omega-3 nutritional oils derived from microalgae.
- The company refines and concentrates oils using proprietary QualitySilver and GreenSilver technologies at its La Forêt-Fouesnant site.
- Polaris supplies B2B customers in nutraceuticals, infant nutrition, and cosmetics; about two-thirds of revenue comes from international markets.
- Management targets doubling the business within five years, prioritizing U.S. expansion, innovation investment, and potential bolt-on acquisitions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Motion Equity Partners SAS published the original content used to generate this news brief on June 11, 2026, and is solely responsible for the information contained therein.
